Changes in rat liver fatty acid profile in experimental non-alcoholic steatohepatitis

Introduction. Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease in the world. Non-alcoholic steatohepatitis (NASH), a clinically progressive morphological form of NAFLD, ranks second in the list of reasons for liver transplantation in the adult population. In the pathogenesi...

Full description

Bibliographic Details
Main Authors:	E. B. Shustov, A. V. Bunjat, A. G. Platonova, O. M. Spasenkova, N. V. Kirillova, D. Yu. Ivkin, S. V. Okovityi, A. N. Kimaev
Format:	Article
Language:	Russian
Published:	LLC Center of Pharmaceutical Analytics (LLC «CPHA») 2021-12-01
Series:	Разработка и регистрация лекарственных средств
Subjects:	fatty acids sterols steatohepatitis non-alcoholic fatty liver disease gas chromatography-mass spectrometry hypercaloric diet hypodynamia
Online Access:	https://www.pharmjournal.ru/jour/article/view/1121

Similar Items

Modification of a model of non-alcoholic fat liver disease in rats with a сombination of a hypercaloric diet and hypodynamia
by: A. V. Bunjat, et al.
Published: (2021-12-01)

Experimental murine non-alcoholic steatohepatitis is associated with behavioural, cognitive, and peripheral neuronal dysfunction
by: V. A. Prikhodko, et al.
Published: (2023-09-01)

Glycyrrhizinic Acid and Phosphatidylcholine Combination as a Preventive Therapy for Experimental Murine Non-Alcoholic Steatohepatitis
by: Veronika A. Prikhodko, et al.
Published: (2024-01-01)

Pharmacotherapy for Non-Alcoholic Fatty Liver Disease: Emerging Targets and Drug Candidates
by: Veronika A. Prikhodko, et al.
Published: (2022-01-01)

Changes in Sterols, Fatty Alcohol and Triterpenic Alcohol during Ripe Olive Processing
by: A. López-López, et al.
Published: (2009-06-01)

Unlocking the Therapeutic Potential of Ellagic Acid for Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis
by: Tharani Senavirathna, et al.
Published: (2024-04-01)

Fructo-oligosaccharides ameliorate steatohepatitis, visceral adiposity, and associated chronic inflammation via increased production of short-chain fatty acids in a mouse model of non-alcoholic steatohepatitis
by: Atsuko Takai, et al.
Published: (2020-02-01)

Acute steatohepatitis, due to extreme metabolic dysregulation, as the first presentation of non-alcoholic fatty liver disease
by: Georgios Kranidiotis, et al.
Published: (2013-05-01)

Non-alcoholic Steatohepatitis: An Overview
by: Allison Shifflet, et al.
Published: (2009-01-01)

Fatty acid composition of blood serum and erythrocyte membranes in men with steatosis and steatohepatitis with normal transaminase activity
by: M. V. Kruchinina, et al.
Published: (2024-07-01)

Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis
by: Kuei-Chuan Lee, et al.
Published: (2023-01-01)

Identification of a Fatty Acid for Diagnosing Non-Alcoholic Steatohepatitis in Patients with Severe Obesity Undergoing Metabolic Surgery
by: Naoto Takahashi, et al.
Published: (2022-11-01)

Dietary fatty acids and risk of non-alcoholic steatohepatitis: A national study in the United States
by: Xiao-Ting Lu, et al.
Published: (2022-07-01)

Assessing whether serum ceruloplasmin promotes non-alcoholic steatohepatitis via regulating iron metabolism
by: Xia Ziqiang, et al.
Published: (2023-01-01)

Steatohepatitis in Children with Obesity
by: Alexander A. Zvyagin, et al.
Published: (2021-08-01)

Liver Injury and Cell Survival in Non-Alcoholic Steatohepatitis Regulated by Sex-Based Difference through B Cell Lymphoma 6
by: Akihide Kamiya, et al.
Published: (2022-11-01)

The Role of Interferon Regulatory Factors in Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis
by: Chunye Zhang, et al.
Published: (2022-04-01)

Non-alcoholic fatty liver disease: Definition and subtypes
by: Seul Ki Han, et al.
Published: (2023-02-01)

Activation and Functional Priming of Blood Neutrophils in Non-Alcoholic Fatty Liver Disease Increases in Non-Alcoholic Steatohepatitis
by: Lauszus JS, et al.
Published: (2021-11-01)

Transcriptional and Epigenetic Alterations in the Progression of Non-Alcoholic Fatty Liver Disease and Biomarkers Helping to Diagnose Non-Alcoholic Steatohepatitis
by: Yalan Zhu, et al.
Published: (2023-03-01)

Non-alcoholic fatty liver disease and cardiovascular pathology: pathogenetic parallels
by: G. Yu. Knorring, et al.
Published: (2024-08-01)

Nonalcoholic steatohepatitis and hepatocellular carcinoma: Brazilian survey
by: Helma P. Cotrim, et al.
Published: (2016-05-01)

Lipidomic identification of urinary extracellular vesicles for non-alcoholic steatohepatitis diagnosis
by: Qingfu Zhu, et al.
Published: (2022-07-01)

The Neutrophil-to-Lymphocyte Ratio as A Noninvasive Marker in Patients with Biopsy-Proven Non-Alcoholic Steatohepatitis
by: Mehmet Asıl, et al.
Published: (2016-12-01)

Rapid Recovery from Acute Liver Failure Secondary to Pancreatoduodenectomy-Related Non-Alcoholic Steatohepatitis
by: Kazushige Nirei, et al.
Published: (2013-01-01)

Correspondence on Letter regarding “Non-alcoholic fatty liver disease: Definition and subtypes”
by: Seul Ki Han, et al.
Published: (2023-07-01)

Use of a controlled attenuation parameter for the diagnosis of non-alcoholic fatty liver disease
by: Alexey A. Goncharov, et al.
Published: (2023-10-01)

Diagnostic accuracy of FibroScan-AST (FAST) score, non-alcoholic fatty liver fibrosis score (NFS), FibroScan, and liver fibrosis index (FIB-4) for identifying fibrotic non-alcoholic steatohepatitis in patients with chronic hepatitis B with metabolic dysfunction-associated fatty liver disease
by: Youwen Tan, et al.
Published: (2024-12-01)

Coronary Artery Disease is More Severe in Patients with Non-Alcoholic Steatohepatitis than Fatty Liver
by: Toshihiro Niikura, et al.
Published: (2020-02-01)

Relationship between serum 25-hydroxyvitamine D and non-alcoholic fatty liver disease
by: S.M. Tkach, et al.
Published: (2023-05-01)

Prevalence of Small Intestinal Bacterial Overgrowth Syndrome in Patients with Non-Alcoholic Fatty Liver Disease/Non-Alcoholic Steatohepatitis: A Cross-Sectional Study
by: Paraskevas Gkolfakis, et al.
Published: (2023-03-01)

Methodical approaches in experimental modelling of non-alcoholic fatty liver disease
by: N. V. Bivalkevich, et al.
Published: (2015-09-01)

Presence and Implications of Sarcopenia in Non-alcoholic Steatohepatitis
by: Gregory Habig, et al.
Published: (2021-04-01)

A Gas Chromatography-Mass Spectrometry Method for the Determination of Fatty Acids and Sterols in Yeast and Grape Juice
by: Cody Williams, et al.
Published: (2021-06-01)

Molecular mechanisms of metabolic disease-associated hepatic inflammation in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
by: Chunye Zhang, et al.
Published: (2023-10-01)

Role of silymarin in the management of deranged liver function in non-alcoholic steatohepatitis: a case report
by: Yeong Yeh Lee, et al.
Published: (2023-01-01)

Progressive Liver Fibrosis in Non-Alcoholic Fatty Liver Disease
by: Daryl Ramai, et al.
Published: (2021-12-01)

Application of ursodeoxycholic acid at non-alcoholic and alcohol-induced steatohepatitis
by: Ye. A. Fedos’ina, et al.
Published: (2010-06-01)

Plasma Fatty Acid Composition Is Associated with Histological Findings of Nonalcoholic Steatohepatitis
by: Teruki Miyake, et al.
Published: (2022-10-01)

Non-alcoholic fatty liver disease development: A multifactorial pathogenic phenomena
by: Aamir Bashir, et al.
Published: (2022-06-01)